Researcher
Piet STINISSEN
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, Inflammation, Genetics, Neurological and neuromuscular diseases
Affiliations
- Limburg Clinical Research Center (Research Center)
Responsible
From1 Sep 2022 → Today - Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Responsible
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From1 Oct 2005 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Jan 1999 → Today - Biomedical Research Institute (Research institute)
Responsible
From1 Oct 2005 → 10 Nov 2009 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From1 Jan 1999 → 30 Sep 2009 - Immunology - Biochemistry (Research group)
Member
From1 Jan 1992 → 31 Dec 2019 - Immunology - Biochemistry (Research group)
Responsible
From1 Jan 1992 → 31 Dec 2019
Projects
1 - 10 of 62
- IOF mandate Limburg Clinical Research Center (LCRC) 2024-2028From1 Jan 2024 → TodayFunding: IOF - mandates
- Structural funding of the LCRC centerFrom1 Jan 2024 → TodayFunding: BOF - research organisations
- Return to work through primary care: The development of a toolkit for general practitionersFrom1 Jan 2024 → TodayFunding: Department of Economy, Science and Innovation
- Donation agreement between Hasselt University, Mylan EPD BV and Noorderhart vzw regarding UMSC.From20 Dec 2022 → 20 Apr 2023Funding: Nonprofit institution or equivalents
- Integrated approach through first-line zones for reintegration into the labor market among the long-term sickFrom19 Dec 2022 → 18 Dec 2023Funding: Department of Economy, Science and Innovation
- Translational MS research UMSC.From29 Sep 2022 → 31 Dec 2022Funding: Industrial enterprises
- Unravelling the mechanism of single time vaccination strategy (SinTimVaS)From21 Feb 2022 → 31 Dec 2022Funding: BOF - projects
- NEURONET - Phase IIIFrom1 Feb 2022 → TodayFunding: BOF - Methusalem
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- DigiPath: The introduction of digital pathology in LimburgFrom16 Dec 2021 → TodayFunding: Provinces, Own budget, for example: patrimony, inscription fees, gifts
Publications
41 - 50 of 158
- High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the Renin Angiotensin system.(2014)
Authors: Silke TIMMERMANS, Jeroen BOGIE, Tim VANMIERLO, Dieter Lütjohann, Piet STINISSEN, Niels HELLINGS, Jerome HENDRIKS
Pages: 209 - 217 - Taking a closer look at Spag16 in multiple sclerosis(2014)
Authors: Laura DE BOCK, Klaartje SOMERS, Judith FRAUSSEN, Jerome HENDRIKS, Jack VAN HORSSEN, Myrthe ROUWETTE, Niels HELLINGS, Luisa M. Villar, Jose C. Alvarez-Cermeno, Raymond Hupperts, et al.
Pages: 14 - 14 - Leukemia inhibitory factor shifts the immune balance towards regulatory T cells(2014)
Authors: Kris JANSSENS, Chris Van den Haute, Veerle Baekelandt, Jack VAN HORSSEN, Bart VAN WIJMEERSCH, Piet STINISSEN, Jerome HENDRIKS, Leen SLAETS, Niels HELLINGS
Pages: 155 - 155 - Macrophage subsets and microglia in multiple sclerosis(2014)
Authors: Jeroen BOGIE, Piet STINISSEN, Jerome HENDRIKS
Pages: 191 - 213 - HLA-E restricted CD8+ T cell subsets are phenotypically altered in multiple sclerosis patients.(2014)
Authors: Kim PANNEMANS, Bieke BROUX, An Goris, Bénédicte Dubois, Tom BROEKMANS, Bart VAN WIJMEERSCH, Daniel Geraghty, Piet STINISSEN, Niels HELLINGS
Pages: 790 - 801 - The influence of interleukin-7 receptor alpha-chain haplotypes on outcome after allogeneic hematopoietic cell transplantation(2014)
Authors: Bieke BROUX, Z. Shamim, T. Wang, S. Spellman, M. Haagenson, Piet STINISSEN, L. P. Ryder, K. Muller, Niels HELLINGS
Pages: 521 - 527 - Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study(2014)
Authors: Nele CLAES, Tessa DHAEZE, Judith FRAUSSEN, Bieke BROUX, Bart VAN WIJMEERSCH, Piet STINISSEN, Niels HELLINGS, Veerle SOMERS, Raymond Hupperts
Pages: 1 - 8 - Human Wharton's jelly-derived stem cells display immunomodulatory properties and transiently improve rat experimental autoimmune encephalomyelitis.(2014)
Authors: Raf DONDERS, Marjan VANHEUSDEN, Jeroen BOGIE, Stelios RAVANIDIS, Kristof THEWISSEN, Piet STINISSEN, Wilfried GYSELAERS, Jerome HENDRIKS, Niels HELLINGS
Pages: 2077 - 2098 - Seroconversion and Fluctuation of Current and Novel Biomarkers during Disease Course of RA(2014)
Authors: Liesbeth DE WINTER, Wendy HANSEN, Piet GEUSENS, Johan VANHOOF, Piet STINISSEN, Veerle SOMERS
Pages: 891 - 891 - Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients(2014)
Authors: Laura VISCONTI, Katherine NELISSEN, Laura Deckx, Marjan van den Akker, Wim Adriaensen, Liesbeth Daniels, Cathy Mathei, Loes LINSEN, Niels HELLINGS, Piet STINISSEN, et al.
Pages: 297 - 306
Patents
1 - 9 of 9
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- METABOLIC MARKERS FOR DIAGNOSING OF CANCER (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)